MX2017016671A - Solucion de isoxazolina que contiene vitamina e para usarse con agua potable desinfectada. - Google Patents

Solucion de isoxazolina que contiene vitamina e para usarse con agua potable desinfectada.

Info

Publication number
MX2017016671A
MX2017016671A MX2017016671A MX2017016671A MX2017016671A MX 2017016671 A MX2017016671 A MX 2017016671A MX 2017016671 A MX2017016671 A MX 2017016671A MX 2017016671 A MX2017016671 A MX 2017016671A MX 2017016671 A MX2017016671 A MX 2017016671A
Authority
MX
Mexico
Prior art keywords
drinking water
isoxazoline
sanitized
solution containing
vitamin
Prior art date
Application number
MX2017016671A
Other languages
English (en)
Inventor
Annie Flochlay-Sigognault
LEHAY Anne
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2017016671A publication Critical patent/MX2017016671A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Preparation (AREA)
  • Ceramic Engineering (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Fodder In General (AREA)
  • Mechanical Engineering (AREA)

Abstract

Para la prevención de infestación por parásitos de animales, una isoxazolina se puede administrar por vía de agua potable; sin embargo, los inventores han encontrado que cuando se desinfecta el agua potable, por ejemplo al utilizar hipoclorito, la isoxazolina se degrada; de manera sorprendente, la isoxazolina se puede proteger de la degradación por medio del uso de una vitamina E; una composición farmacéutica ahora se puede preparar la cual contiene una solución concentrada de la isoxazolina en un solvente y co-solvente, con vitamina E; la composición se puede diluir en agua potable, incluso cuando se desinfecta, para preparar agua potable medicada para animales; de esta forma, un tratamiento antiparasitario se puede administrar en masa, lo que conduce a una reducción altamente significativa de la infestación por parásitos de un animal y sus alrededores.
MX2017016671A 2015-06-23 2016-06-22 Solucion de isoxazolina que contiene vitamina e para usarse con agua potable desinfectada. MX2017016671A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15173454 2015-06-23
PCT/EP2016/064449 WO2016207234A1 (en) 2015-06-23 2016-06-22 Isoxazoline solution containing vitamin e for use with sanitized drinking water

Publications (1)

Publication Number Publication Date
MX2017016671A true MX2017016671A (es) 2018-03-15

Family

ID=53488226

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017016671A MX2017016671A (es) 2015-06-23 2016-06-22 Solucion de isoxazolina que contiene vitamina e para usarse con agua potable desinfectada.

Country Status (10)

Country Link
US (3) US20180169073A1 (es)
EP (1) EP3313400B1 (es)
JP (1) JP6933983B2 (es)
CN (1) CN107750159B (es)
BR (1) BR112017027855B1 (es)
ES (1) ES2920394T3 (es)
HU (1) HUE059228T2 (es)
MX (1) MX2017016671A (es)
PL (1) PL3313400T3 (es)
WO (1) WO2016207234A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3003109A1 (en) * 2015-10-28 2017-05-04 Yuhan Corporation Long-acting fgf21 fusion proteins and pharmaceutical composition comprising same
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
IL307992A (en) 2017-12-15 2023-12-01 Tarsus Pharmaceuticals Inc Parasitic formulations containing isoxazoline and methods for treating blepharitis
CN114306231B (zh) * 2021-12-29 2023-03-24 天津市中升挑战生物科技有限公司 一种氟雷拉纳杀虫剂及其制备方法和应用
CN115266988A (zh) * 2022-08-01 2022-11-01 江苏慧聚药业股份有限公司 一种氟雷拉钠有关物质的检测方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962488A (en) * 1998-04-08 1999-10-05 Roberts Laboratories, Inc. Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
WO2002000557A2 (en) 2000-06-27 2002-01-03 The Procter & Gamble Company Water treatment compositions
US20050005868A1 (en) * 2003-07-11 2005-01-13 Shepard Allan T. Animal drinking water production
ZA200607637B (en) 2004-03-05 2008-05-28 Nissan Chemical Ind Ltd Isoxazoline-substituted benzamide compound and noxious organism control agent
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
JP2007319124A (ja) * 2006-06-02 2007-12-13 Nippon Tablet Kk 健康食品
AU2008235089B8 (en) 2007-04-10 2014-04-10 Bayer Intellectual Property Gmbh Insecticidal aryl isoxazoline derivatives
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
KR101714291B1 (ko) 2007-06-27 2017-03-08 이 아이 듀폰 디 네모아 앤드 캄파니 동물 해충 방제 방법
US20090024541A1 (en) * 2007-07-20 2009-01-22 Gary Kremen Power purchase methods, agreements and financial instruments for tax-advantaged financing residential renewable energy equipment
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
CN102088856B (zh) * 2008-07-09 2015-11-25 巴斯夫欧洲公司 包含异*唑啉化合物的杀虫活性混合物i
US7951404B2 (en) * 2008-07-11 2011-05-31 Sanosil Ag Concentrate for preparing a disinfectant and methods for its preparation and use
US8377942B2 (en) 2008-12-18 2013-02-19 Novartis Ag Isoxazolines derivatives and their use as pesticide
AR074790A1 (es) 2008-12-19 2011-02-09 Novartis Ag Derivados de isooxazol sustituidos, composiciones farmaceuticas y para el control de parasitos que los comprenden y su uso en metodos para controlar parasitos en y sobre animales de sangre caliente.
WO2011075591A1 (en) 2009-12-17 2011-06-23 Merial Limited Anti parasitic dihydroazole compounds and compositions comprising same
WO2011092287A1 (en) 2010-02-01 2011-08-04 Basf Se Substituted ketonic isoxazoline compounds and derivatives for combating animal pests
CN102933563A (zh) 2010-04-08 2013-02-13 Ah美国42有限责任公司 作为杀虫剂和杀螨剂的取代的3,5-二苯基异噁唑啉衍生物
WO2012155352A1 (en) 2011-05-19 2012-11-22 Eli Lilly And Company Dihydroisoxazole compounds, parasiticidal uses and formulations thereof
MX2014002092A (es) 2011-08-25 2014-04-25 Syngenta Participations Ag Derivados de isoxazolina como compuestos insecticidas.
WO2013026695A1 (en) 2011-08-25 2013-02-28 Syngenta Participations Ag Isoxazoline derivatives as insecticidal compounds
HUE052594T2 (hu) * 2011-09-12 2021-05-28 Boehringer Ingelheim Animal Health Usa Inc Izoxazolint tartalmazó parazita-ellenes készítmények, ezek elõállítása és alkalmazása
EP3052080A1 (en) 2013-09-30 2016-08-10 Zoetis Services LLC Long-acting spiro-isoxazoline formulations
US9371293B2 (en) 2013-10-25 2016-06-21 Sumitomo Chemical Company, Limited Isoxazoline compound composition
EP3063144B1 (en) 2013-11-01 2021-09-08 Boehringer Ingelheim Animal Health USA Inc. Antiparasitic and pesticidal isoxazoline compounds
AU2014363695B2 (en) * 2013-12-10 2018-12-13 Intervet International B.V Antiparasitic use of isoxazoline compounds
EP3082867B1 (en) * 2013-12-20 2024-01-17 Intervet International B.V. Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals
EP3878281B1 (en) * 2013-12-20 2023-05-24 Intervet International B.V. Use of isoxazoline compounds in poultry
CA2965524C (en) * 2014-11-03 2020-04-14 Zoetis Services Llc Palatable chewable veterinary composition

Also Published As

Publication number Publication date
JP6933983B2 (ja) 2021-09-08
US11179372B2 (en) 2021-11-23
ES2920394T3 (es) 2022-08-03
CN107750159A (zh) 2018-03-02
EP3313400B1 (en) 2022-06-15
US20210354283A1 (en) 2021-11-18
EP3313400A1 (en) 2018-05-02
US20190343808A1 (en) 2019-11-14
US11878006B2 (en) 2024-01-23
BR112017027855A2 (es) 2018-08-21
WO2016207234A1 (en) 2016-12-29
CN107750159B (zh) 2021-10-29
US20180169073A1 (en) 2018-06-21
JP2018521995A (ja) 2018-08-09
PL3313400T3 (pl) 2022-07-25
BR112017027855B1 (pt) 2022-11-16
HUE059228T2 (hu) 2022-10-28

Similar Documents

Publication Publication Date Title
MX2017016671A (es) Solucion de isoxazolina que contiene vitamina e para usarse con agua potable desinfectada.
EA201691988A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MX2020009010A (es) Formulaciones inyectables de larga duracion que comprenden un agente activo de isoxazolina, metodos y usos de las mismas.
MX2022010831A (es) Formulaciones inyectables de liberacion extendida que comprenden un agente activo de isoxazolina, metodos y usos de las mismas.
EA201691845A1 (ru) Фармацевтические композиции терапевтически активных соединений
EP4306168A3 (en) Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals
EA201691844A1 (ru) Фармацевтические композиции терапевтически активных соединений
CL2017001483A1 (es) Formulación de relación fija de insulina glargina/lixisenatida
MX2020010997A (es) Uso de derivados de isoxazolina para el tratamiento o prevencion de infestaciones por artropodos en aves de corral.
CL2015002319A1 (es) Dispositivo y sistema para el tratamiento de peces.
MX2017003205A (es) Composiciones antimicrobianas y sus metodos de uso.
MX2017006709A (es) Agente para prevenir o mejorar sintomas causados por desequilibrio de las hormonas sexuales.
MX2018000611A (es) Sistemas mejorados de entrega de nanoparticula.
EP3313380A4 (en) COMPOSITION FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES TO AN ANIMAL
MX2022011564A (es) Tratamiento del dolor.
CL2020003153A1 (es) Composiciones antimicrobianas con agentes efervescentes (divisional de solicitud n° 03273-2016)
MX2017011040A (es) Agente para el tratamiento de infeccion respiratoria.
MX2017004899A (es) Compuestos derivado de pirazolina y su uso en una pauta posológica semanal contra la inflamación y el dolor derivados de la enfermedad articular degenerativa en mamíferos.
GB2550750A (en) Anthelmintic compounds
CL2016003271A1 (es) Métodos para tratar infecciones
EA201890911A1 (ru) Комбинация тразодона и габапентина для лечения боли
AU2014353885A8 (en) Prevention and treatment of toxicosis
EA201300351A1 (ru) Инъекционная ветеринарная композиция в виде раствора для борьбы с полиинвазиями животного и способ ее получения
EA201300956A1 (ru) Фармацевтическая композиция
EA201590527A1 (ru) Фармацевтическая композиция